Page 253 - Malaysia 2016
P. 253
2016 253
Inno Biologics Minister, Nanotechnology was identified
as one of the new growth engines
Inno Biologics is an agency specialising for the New Economic Model (NEM).
in mammalian cell culture technology
and the operations of a state-of- On the 14th of February 2011, the
the-art cGMP for the production of
biopharmaceuticals. This facility was National Innovation Council convened
built to comply with the European
Medicines Agency (EMEA) and the U.S. and agreed that a nanotechnology
Food and Drug Administration (FDA).
The Agency offers complete services commercialisation agency was needed
from the beginning to the completion
of the operations for the development and corresponding activities must be
of therapeutic proteins. The handling,
speed and cost of effective services will aligned with Agensi Inovasi Malaysia’s
reduce the risk, cost and investment time.
(AIM) initiatives. NanoMalaysia Berhad
was incorporated in 2011 as a company
limited by guarantee (CLG) under the
Ministry of Science, Technology and
Innovation (MOSTI) to act as a business
entity entrusted with nanotechnology
commercialisation activities. Some
of its roles include Commercialisation
Inno Biologics Sdn. Bhd. of Nanotechnology Research and
Lot 1, Persiaran Negeri BBN, Putra Nilai,
71800 Nilai, Negeri Sembilan Development, Industrialisation of
Tel: 06-799 6661 | Fax: 06-799 6660
Website: www.innobiologics.com Nanotechnology, Facilitation of
National Institutes of Biotechnology Investments in Nanotechnology and
Malaysia (NIBM)
Human Capital Development in
Nanotechnology.
NIBM is a consortium that combines NanoMalaysia Berhad
A-2-2 & A-2-3 Aras 2,
Malaysia Agro-Biotechnology 157 Hampshire Place Office,
No. 1 Jalan Mayang Sari,
Institute (ABI), Malaysia Institute of 50450 Kuala Lumpur
Tel: 03-2166 8849 | Fax: 03-2181 8849
Pharmaceuticals and Nutraceuticals Website: www.nanomalaysia.com.my
(IPHARM) and Malaysia Genome Institute
(MGI). NIBM is an autonomous entity Malaysian Foundation for Innovation
(YIM)
formed by NIBM Corporation agreement
on 21 May 2014 and responsible to
lead, coordinate and implement the Malaysian Foundation for Innovation was
established in October 2008 and was
national biotechnology agenda through approved by the Malaysian Cabinet on
7-November 2008. The vision of YIM is to
research, development, innovation and promote and inculcate creativity and
innovation among Malaysian citizens.
commercialization (RDIC) activities. Innovation is the engine that will propel
us to that future.
National Biotechnology Institutes Malaysia
(NIBM) Malaysian Foundation for Innovation
Level 2, Complex Institut Agro Biotech Unit E001, Ground Floor, Block 3440,
Malaysia (ABI), Enterprise Building, No. 1, Jalan Teknokrat 3,
MARDI, 43400, Serdang 63000 Cyberjaya, Selangor
Tel: 03-8949 5600 | Fax: 03-8940 8692 Tel: 03-8319 1714 | Fax: 03-8319 1715
Website: www.nibm.my Website: www.yim.my
NANOMALAYSIA BERHAD
In the National Innovation Council
meeting on the 29th of October 2009
chaired by the Right Honorable Prime
Inno Biologics Minister, Nanotechnology was identified
as one of the new growth engines
Inno Biologics is an agency specialising for the New Economic Model (NEM).
in mammalian cell culture technology
and the operations of a state-of- On the 14th of February 2011, the
the-art cGMP for the production of
biopharmaceuticals. This facility was National Innovation Council convened
built to comply with the European
Medicines Agency (EMEA) and the U.S. and agreed that a nanotechnology
Food and Drug Administration (FDA).
The Agency offers complete services commercialisation agency was needed
from the beginning to the completion
of the operations for the development and corresponding activities must be
of therapeutic proteins. The handling,
speed and cost of effective services will aligned with Agensi Inovasi Malaysia’s
reduce the risk, cost and investment time.
(AIM) initiatives. NanoMalaysia Berhad
was incorporated in 2011 as a company
limited by guarantee (CLG) under the
Ministry of Science, Technology and
Innovation (MOSTI) to act as a business
entity entrusted with nanotechnology
commercialisation activities. Some
of its roles include Commercialisation
Inno Biologics Sdn. Bhd. of Nanotechnology Research and
Lot 1, Persiaran Negeri BBN, Putra Nilai,
71800 Nilai, Negeri Sembilan Development, Industrialisation of
Tel: 06-799 6661 | Fax: 06-799 6660
Website: www.innobiologics.com Nanotechnology, Facilitation of
National Institutes of Biotechnology Investments in Nanotechnology and
Malaysia (NIBM)
Human Capital Development in
Nanotechnology.
NIBM is a consortium that combines NanoMalaysia Berhad
A-2-2 & A-2-3 Aras 2,
Malaysia Agro-Biotechnology 157 Hampshire Place Office,
No. 1 Jalan Mayang Sari,
Institute (ABI), Malaysia Institute of 50450 Kuala Lumpur
Tel: 03-2166 8849 | Fax: 03-2181 8849
Pharmaceuticals and Nutraceuticals Website: www.nanomalaysia.com.my
(IPHARM) and Malaysia Genome Institute
(MGI). NIBM is an autonomous entity Malaysian Foundation for Innovation
(YIM)
formed by NIBM Corporation agreement
on 21 May 2014 and responsible to
lead, coordinate and implement the Malaysian Foundation for Innovation was
established in October 2008 and was
national biotechnology agenda through approved by the Malaysian Cabinet on
7-November 2008. The vision of YIM is to
research, development, innovation and promote and inculcate creativity and
innovation among Malaysian citizens.
commercialization (RDIC) activities. Innovation is the engine that will propel
us to that future.
National Biotechnology Institutes Malaysia
(NIBM) Malaysian Foundation for Innovation
Level 2, Complex Institut Agro Biotech Unit E001, Ground Floor, Block 3440,
Malaysia (ABI), Enterprise Building, No. 1, Jalan Teknokrat 3,
MARDI, 43400, Serdang 63000 Cyberjaya, Selangor
Tel: 03-8949 5600 | Fax: 03-8940 8692 Tel: 03-8319 1714 | Fax: 03-8319 1715
Website: www.nibm.my Website: www.yim.my
NANOMALAYSIA BERHAD
In the National Innovation Council
meeting on the 29th of October 2009
chaired by the Right Honorable Prime
